Chang L J, Zhang C
Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Canada.
Virology. 1995 Aug 1;211(1):157-69. doi: 10.1006/viro.1995.1388.
Tat is an essential regulatory protein for the replication of human immunodeficiency virus (HIV). Mutations in the tat gene have been shown to block HIV replication in human T cells. Several studies have established that Tat releases an elongation block to the transcription of HIV long terminal repeat (LTR); however, it is not known whether this mechanism alone is sufficient to explain the block to HIV replication in human T cells when Tat is absent. It is possible that Tat is also needed for other functions during HIV replication. To test these hypotheses, we studied several tat mutants, including two stop codon mutants and one deletion mutant using replication-competent HIV-1 constructs carrying wild-type or mutant LTRs with modifications in the NF-kappa B and/or Sp1 binding sites. In this study, we show that Tat- HIV-1 with wild-type LTRs can replicate in HeLa cells, and the virus produced from HeLa cells can infect primary peripheral blood lymphocytes and macrophages. It was found that the propagation of the Tat mutants containing wild-type LTRs was less efficient than that of the LTR-modified Tat mutants. Large amounts of viral RNA and particles were synthesized in infections established using the tat mutants that contain modified LTRs. However, this efficient propagation of the LTR-modified tat mutants was restricted to some lymphoid cell lines that have been transformed with other viruses. Thus, despite its essential role for releasing an elongation block, Tat is not otherwise absolutely required for synthesis of full-length HIV transcripts and assembly of virus particles. Direct sequencing of the viral genomes and reinfection kinetics showed no evidence of wild-type reversion even after prolonged infection with the Tat- virus. The implications for in vivo HIV-1 replication and potential application of this system to the study of alternative Tat function are discussed.
Tat是人类免疫缺陷病毒(HIV)复制所必需的调节蛋白。已表明tat基因中的突变会阻断HIV在人T细胞中的复制。多项研究证实,Tat可解除对HIV长末端重复序列(LTR)转录的延伸阻滞;然而,尚不清楚当不存在Tat时,仅这一机制是否足以解释HIV在人T细胞中复制的阻滞现象。在HIV复制过程中,Tat可能还需要发挥其他功能。为了验证这些假设,我们使用携带野生型或突变型LTR且在NF-κB和/或Sp1结合位点有修饰的具有复制能力的HIV-1构建体,研究了几种tat突变体,包括两个终止密码子突变体和一个缺失突变体。在本研究中,我们发现具有野生型LTR的Tat-HIV-1能够在HeLa细胞中复制,并且从HeLa细胞产生的病毒能够感染原代外周血淋巴细胞和巨噬细胞。结果发现,含有野生型LTR的Tat突变体的增殖效率低于LTR修饰的Tat突变体。在使用含有修饰LTR的tat突变体建立的感染中,合成了大量的病毒RNA和病毒颗粒。然而,LTR修饰的tat突变体的这种高效增殖仅限于一些已被其他病毒转化的淋巴样细胞系。因此,尽管Tat在解除延伸阻滞方面起着至关重要的作用,但在全长HIV转录本的合成和病毒颗粒的组装方面,Tat并非绝对必需。对病毒基因组的直接测序和再感染动力学研究表明,即使在用Tat缺陷病毒长时间感染后,也没有野生型回复的证据。本文还讨论了该研究结果对体内HIV-1复制的意义以及该系统在研究Tat替代功能方面的潜在应用。